期刊文献+

尿多酸肽对原代红系细胞γ-珠蛋白表达的体外研究 被引量:1

In vitro study of urinary polypeptide on expression ofγ-globin in primary erythrocytes
下载PDF
导出
摘要 目的:探讨尿多酸肽(CDA-Ⅱ)对体外培养原代红系细胞γ-珠蛋白基因和蛋白表达的影响,为CDA-Ⅱ对β-地中海贫血的治疗提供新思路。方法:以不同浓度CDA-Ⅱ(0 mg/mL、1 mg/mL、2 mg/mL、3 mg/mL、4 mg/mL)作用原代红系细胞24 h、48 h和72 h,采用实时荧光定量聚合酶链反应(RT-PCR)和Cell counting kit-8(CCK-8)法分别检测γ-珠蛋白基因的表达及细胞增殖-毒性情况;以3 mg/mL CDA-Ⅱ为实验组、200 nmol/L地西他滨和100μmol/L羟基脲为阳性对照组以及等体积PBS+DMSO为阴性对照组作用细胞后,采用RT-PCR检测γ-珠蛋白、DNA甲基转移酶1(DNMT1)和FOXO3a mRNA表达的变化;Western Blot(WB)检测γ-珠蛋白表达的情况。结果:RT-PCR结果表明,3 mg/mL CDA-Ⅱ作用细胞48 h和72h后上调γ-珠蛋白基因的表达作用明显(P<0.05),分别为空白对照组(0 mg/mL)的2.5倍和2.68倍;CCK-8结果显示细胞存活率存在时间和浓度依赖性下降,24 h、48 h和72 h的半数抑制浓度(IC50)分别为(5.28±0.67)mg/mL、(3.89±0.63)mg/mL、(2.35±0.20)mg/mL;与阴性对照组比较,CDA-Ⅱ组与地西他滨、羟基脲阳性对照组既可以降低DNMT1基因的表达(P<0.05)、升高FOXO3a基因的表达,同时可以上调γ-珠蛋白基因和蛋白的表达(P<0.01)。结论:CDA-Ⅱ对红系细胞γ-珠蛋白基因和蛋白的高表达可能与DNMT1和FOXO3a有关。 Objective: To investigate the effect of urinary polypeptide(CDA-Ⅱ)on the expression of γ-globin gene and protein in primary erythrocytes cells in vitro,and to provide a new concept for the treatment of β-thalassemia by CDA-Ⅱ.Methods: Primary erythroid cells were treated with different concentrations of CDA-Ⅱ(0 mg/mL,1 mg/mL,2 mg/mL,3 mg/mL,4 mg/mL)for 24 h,48 h,and 72 h,the expression of γ-globin gene and cell proliferation-toxicity were detected by real-time fluorescence quantitative polymerase chain reaction(RT-qPCR)and Cell counting kit-8(CCK-8),respectively.The γ-globin DNA methyltransferase1(DNMT1)and FOXO3 a mRNA expression were detected by RT-qPCR after cells treated with 3 mg/mL of CDA-Ⅱ(CDA-Ⅱ experimental group),200 nmol/L of decitabine and 100 μmol/L of hydroxyurea(two positive control group),and equal volume PBS+DMSO(negative control group).The expression of γ-globin was detected by Western blot(WB).Results: The results of RT-qPCR showed that the expression of γ-globin gene was significantly up-regulated after treated with 3 mg/mL CDA-Ⅱ for 48 h and 72 h(P<0.05),which was 2.5 and 2.68 times higher than that of the blank control group(0 mg/mL CDA-Ⅱ),respectively.CCK-8 results showed that the cell survival rate was decreased in a time-dependent and concentration-dependent manner.The 50%inhibitory concentration(IC50)at 24 h,48 h,and 72 h were(5.28±0.67)mg/mL,(3.89±0.63)mg/mL,and(2.35 ± 0.20)mg/mL,respectively.Compared with the negative control group,CDA-Ⅱ experimental group,decitabine and hydroxyurea positive control group could decrease the expression of DNMT1 gene(P<0.05),increase the expression of FOXO3 a gene,and up-regulate the expression of γ-globin gene and protein(P<0.01).Conclusion: The effect of in primary erythroid cells CDA-Ⅱ on the high expression of γ-globin gene and protein in erythroid cells may be related to DNMT1 and FOXO3 a.
作者 江雷 方栋 黄语妹 杨高晖 盘玲媛 刘容容 赖永榕 Jiang Lei;Fang Dong;Huang Yushu;Yang Gaohui;Pan Lingyuan;Liu Rongrong;Lai Yongrong(Department of Hematology,The First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China;Guangxi key Laboratory for Prevention and Treatment of Thalassemia,Nanning 530021,China)
出处 《广西医科大学学报》 CAS 2020年第4期599-604,共6页 Journal of Guangxi Medical University
基金 中国医学科学院中央级公益性科研院所基本科研业务费专项资金资助(No.2017PT32012) 广西重大科技创新基地建设项目(No.2018-15-Y01) 国家自然科学基金资助项目(No.81560024)。
关键词 尿多酸肽 γ-珠蛋白 DNMT1 FOXO3A urinary polypeptide γ-globin DNMT1 FOXO3a
  • 相关文献

参考文献2

二级参考文献29

  • 1张俊武,龙桂芳,主编.血红蛋白与血红蛋白病.南宁:广西科学技术出版社.2001.152-264.
  • 2唐智宁,梁徐,梁荣,等.检查珠蛋白肽链诊断a地中海贫血.中华血液学杂志,1988,9(11):687-688.
  • 3Piomellis S, Danoff SJ, Becker MH, et al. Prevention of bone malfor- mations and cardiomegaly in Cooley: anemia by early hypertransfusion regimen. Ann NY Acad Sci, 1969,165 ( 1 ) :427-436.
  • 4Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concen- tration and total body iron stores in thalassemia major. N Engl J Med, 2000,343 (5) :327-331.
  • 5Jensen PD, Jensen FT, Christensen T, et al. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine:indication of close relation between myocardial iron content and ehelatable iron pool. Blood,2003,101 (11 ) :4632-4639.
  • 6St Pierre TG, Clark PR, Chua-anusorn W, et al. Noninvasive measure- ment and imaging of liver iron concentrations using proton magnetic resonance. Blood,2005,105 ( 2 ) :855-61.
  • 7Ghugre NR, Enriquez CM, Gonzalez I, et al. MRI detects myocardial i- ron in the human heart. Magn Reson Med,2006,56 (3) :681-686.
  • 8Wood JC, Otto-Duessel M, Aguilar M, et al. Cardiac iron determines cardiac T2 * , T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation, 2005,112 ( 4 ) : 535-543.
  • 9Cario H ,Janka-Schaub G,Janssen G, et al. Recent developments in i- ron chelation therapy. Klin Padiatr,2007,219 (3) : 158-165.
  • 10Fischer R, Piga A, Harmatz P, et al. Monitoring long-term efficacy of iron chelation treatment with biomagnetie liver suseeptometry. Ann N Y Acad Sei ,2005, (1054) :350-357.

共引文献20

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部